Kalorama InformationKalorama Information, a division of MarketResearch.com, is a leader in worldwide business intelligence and syndicated market research in the life sciences. With a more than 30-year history of providing timely, high-quality research to decision makers in the pharmaceutical, biotechnology, medical device, and diagnostics sectors, Kalorama comprehensively researches the market sectors and healthcare trends that matter most to emerging and established life science firms.
|
View Sample from this Publisher Adobe Acrobat required |
Our Products & Services
Kalorama Information Market Profiles are in-depth analyses of specific markets based on extensive interviews with industry experts, unique market modeling techniques, and comprehensive secondary research. Generally several hundred pages in length, Market Profiles provide market size; growth rates; market share and profiles of market leaders, including technologies, products, and business strategies; and analysis of major clinical, demographic, and regulatory trends.
Kalorama Information MarketLooks are detail- and graphic-rich reports consisting of the top-level findings, charts, and graphs from our longer, full-length Market Profiles. Typically 15-30 pages in length, MarketLooks provide primary research findings from full reports to accommodate those with limited research budgets or limited time to ramp up on a topic. The electronic format of these reports makes them easy to integrate into internal presentations and reports.
Kalorama DeviceLooks are concise profiles of specific medical device markets providing key market information with a strong emphasis on data and graphics. Ranging from 30-50 pages in length, DeviceLooks provide the data that matters for the medical device industry in an affordable format.
Our Team
Steven Heffner, Acquisitions Editor
Steven Heffner has been involved in publishing information for healthcare professionals for 15 years. He began in peer-reviewed clinical literature, editing the Current Opinion line of clinical medical journals. Later, his focus shifted to healthcare books, and held editorships at Faulkner & Gray’s Healthcare Information Center, specializing in books on managed care policy, and most recently at Theta Reports, part of PJB Medical Publishing. Steven joined Kalorama in the spring of 2001. He personally commissions and edits all of Kalorama research studies to ensure that they are consistently of the highest quality. Steven can be reached at sheffner@kaloramainformation.com.
Our Industry Specialists
Kalorama Information’s Industry Specialists are dedicated to serving you and meeting your information needs. Whether you need help browsing through our collection or require advice about which particular research will best suit your needs, our Industry Specialists are here to help. Contact an Industry Specialist today at 1-800-298-5602 or (212) 807-2660 outside the U.S.
Why Buy from Us?
Our Independent Voice
With Kalorama studies you get:
Our Quality Analysts
Kalorama’s analysts are experienced researchers in their fields who provide you with:
Our Research Methodology
Kalorama Information studies include data gathered the old-fashioned way – through primary research. Our market studies are based on independent primary research conducted by analysts with years of experience in the industry. They build their market analysis from the ground up, validating data with inside industry contacts and extensive secondary research, not by regurgitating numbers from an enormous database you already have. Extensive interviewing of industry executives, clinical practitioners, government policy makers, and respected consultants form the basis of every Kalorama study. Secondary sources, such as regulatory filings, company literature, press reports, and commercial databases, are relied upon to validate market assumptions and detail industry events.
List of reports from Kalorama Information
|
3 Key Trends in MRI White Paper
3/6/2012 | published by: Kalorama Information
... applications for this growing imaging modality. This Kalorama White Paper discusses general trends does not replace the thorough analysis in our full survey of the market for MRI - Medical Imaging Markets: MRI and Ultrasound.
|
more...
|
|
|
Advanced Drug Delivery Markets (Liposomes, Polymers and Monoclonal Antibodies)
12/1/2010 | published by: Kalorama Information
... other novel compounds targeting drugs to specific disease sites including gene therapy. Treatments for chronic conditions and growth in patient-administered drugs are factors leading to greater focus on ease-of-use and convenience. Advanced Drug Delivery Markets ...
|
more...
|
$2,500.00
|
|
Advanced Drug Delivery: Technologies, Applications, and Markets
7/1/2003 | published by: Kalorama Information
... earlier stages. In Kalorama’s 2001-2002 Drug Delivery series, we focused on the markets by route of administration—oral, injectable, implantable, pulmonary, transdermal etc. In this all new study on advanced drug delivery, however, we focused on ...
|
more...
|
$2,625.00
|
|
Advanced Drug Delivery: Technologies, Applications, and Markets, 2nd Ed.
11/15/2005 | published by: Kalorama Information
... Taking a strategic view of the various therapeutic areas on which drug delivery is anticipated to have its greatest impact, the report considers the options that the current technologies present, the progress that is being ...
|
more...
|
$2,500.00
|
|
Advanced Polymers for Medical Applications: Materials, Product Development, and Market Opportunities
2/1/2002 | published by: Kalorama Information
... even conductivity, polymers are proving to be more versatile and complex than ever before. Kalorama's Advanced Polymers for Medical Applications examines the latest technological and market developments in advanced plastics for: Diagnostic and laboratory devices ...
|
more...
|
$2,625.00
|
|
Advances in Cancer Therapy
2/1/2001 | published by: Kalorama Information
... many cancer patients are managed as if they were chronically ill. These thoughts are being shaped and driven by a variety of forces: A new paradigm that would make use of the patient's natural immune ...
|
more...
|
$350.00
|
|
Advances in Ophthalmology: Markets in the Treatment of Eye Disorders and Corrective Vision
7/1/2006 | published by: Kalorama Information
... dynamics of this market. As RK and LASIK changed the market a few years ago, even newer competitive technologies are just now emerging. From the advent of photodynamic therapy and new drug delivery techniques to ...
|
more...
|
$2,995.00
|
|
Advances in Ophthalmology: Markets in the Treatment of Eye Disorders and Corrective Vision, 2nd Edition
7/1/2009 | published by: Kalorama Information
... used as the base year with forecasts to the year 2013. Market statistics are given in U.S. dollars and in units [where appropriate]. Basis for the market analysis consists of key data, statistics; references, and ...
|
more...
|
$995.00
|
|
Advertising on the Internet: Implications for Marketers and Advertisers
1/1/1997 | published by: Kalorama Information
... site segmentation for advertising, advertiser segmentation, and an assessment of the role for advertising agencies. A forecast for Web advertising is provided for the aggregate market and by Web site segmentation. Many company profiles included.
|
more...
|
$1,625.00
|
|
Allergy and Asthma Therapeutics
1/1/1996 | published by: Kalorama Information
... to 2000 are provided for allergy segments--antihistamines, corticosteroids, cromolyn sodium, and decongestants--and for asthma segments--beta agonists, corticosteroids, cromolyn sodium, and throphylline. Other major trends are identified, and pharmaceutical companies competing in the market are profiled.
|
more...
|
$1,625.00
|
|
Alternative Drug Delivery Systems
9/1/1995 | published by: Kalorama Information
... The systems featured are those that deliver therapeutic doses to selective targets, with fewer side effects, in ways that instigate greater compliance with the prescription routine while also improving patients' quality of life. The market ...
|
more...
|
$1,625.00
|
|
Alzheimer's Disease: Selections from "The World Market for Neurotherapeutic Drugs"
9/1/2002 | published by: Kalorama Information
... and their treatments in the top seven world health markets. Here we present those parts of that study that are germane to Alzheimer’s disease. In addition to the relevant selections, which are indicated on the ...
|
more...
|
$1,121.00
|
|
Ambulatory Infusion Pumps in Pain Management: A Market Briefing
8/1/2004 | published by: Kalorama Information
... have acted to draw this attention, including the high prevalence of pain, continuing evidence that pain is undertreated and a growing awareness of the negative consequences of poor pain management. Infusion pumps were first introduced ...
|
more...
|
$895.00
|
|
Analytical Chip Technology: U.S. Markets for Lab on a Chip, DNA/Gene, Protein, and other Microarrays, 3rd. Edition
11/1/2007 | published by: Kalorama Information
... as pharmaceutical development, food testing, clinical diagnostics, forensics, and environmental analysis. Kalorama's Analytical Chip Technology: U.S. Markets for Lab on a Chip, DNA/Gene, Protein and other Microarrasys) 3rd. Edition looks at the market for analytical ...
|
more...
|
$995.00
|
|
Anesthesia Drugs: Worldwide Markets
7/1/2007 | published by: Kalorama Information
... are correlated to prevalence and incidence in disease, and the resulting increase in procedure volumes. But as this market continues to grow, increased competition is steadily escalating in the United States and Europe, which is ...
|
more...
|
$2,500.00
|
|
Anti Infectives: World Market, 2nd Edition, Vol II: Antibacterials
4/1/2007 | published by: Kalorama Information
... types of bacteria become resistant to them. These and other developments are covered in Kalorama's Anti-Infectives, World Markets, Vol. II: Antibacterials providing extensive detail on the anti-bacterial market, including the following critical trends: Drug resistance ...
|
more...
|
$2,995.00
|
|
The Anti-Infectives Market
7/1/1999 | published by: Kalorama Information
... Information study offers in-depth coverage of the $9 billion U.S. market for existing and emerging anti-infective drugs. Readers find detailed market analysis, including historical, current and forecast market size, for each of the market segments. ...
|
more...
|
$2,437.00
|
|
Anti-Infectives: World Market, 2nd. Ed., Vol. I: Antifungals
3/1/2007 | published by: Kalorama Information
... steady increase in the incidence of more serious infections. This is partially due to the widespread use of antibiotics, which eliminate or decrease fungi-killing bacteria. The increased number of individuals with reduced immune responses caused ...
|
more...
|
$2,500.00
|
|
Anti-Infectives: World Market, 2nd Edition, Vol III: Antivirals
5/1/2007 | published by: Kalorama Information
... marketed and late stage development antiviral products in detail. For each segment, the report provides: Revenue Data by Infection Type An overview of products on the market Review of products in the development pipeline Market ...
|
more...
|
$2,700.00
|
|
Anti-Infectives: World Markets, 2nd Edition, Vol. I-III (Complete Series)
5/1/2007 | published by: Kalorama Information
... each report includes: Epidemiology including Incidence Statistics for each type of infection. Current Market Size and Revenue Forecasts for each market segment to assist with long term planning. Discussion of Competitive Products in the market ...
|
more...
|
$5,995.00
|
|
Asian American Market
8/1/1995 | published by: Kalorama Information
... essential data and competitive intelligence, including linguistic, demographic and statistical information on Asian-Americans; critical historical and cultural information on each of the major sub-groups (Japanese-, Chinese-, Filipino-, Asian Indian-, Korean- and Vietnamese-Americans); marketing and media ...
|
more...
|
$1,625.00
|
|
Asian In Vitro Diagnostic Markets
10/1/2002 | published by: Kalorama Information
... chemistry, hematology, urinalysis, coagulation and immunochemistry. The instruments working in each of the segments is summarized by company. In chemistry, instrumentation is broken down by three levels of throughput. In critical care, instruments are divided ...
|
more...
|
$2,625.00
|
|
Asian Medical Device Markets (Medical Devices in China, India, Japan, South Korea and Australia)
5/1/2007 | published by: Kalorama Information
... Asia Pacific), rising income and with it, continued growth in healthcare spending makes Asia an important market for makers of medical devices. Kalorama Information's Asian Medical Device Markets is your guide to the market for ...
|
more...
|
$1,995.00
|
|
Asian Vaccine Markets: India, China, Japan, Korea, Indonesia and Rest of Asia
3/25/2011 | published by: Kalorama Information
... people throughout Asia accounts for more than half of the global population, yet currently it is Western markets which lead vaccine sales. This hasn't stopped companies from investing in Asian vaccine markets. The graying of ...
|
more...
|
$3,500.00
|
|
Autism Therapeutics: A Market Briefing
1/15/2005 | published by: Kalorama Information
... some help for patients and garnering revenues for drug companies. This Market Briefing reviews the market for drugs used in the treatment of autism and related disorers, including Antidepressants, Anti-Anxiety drugs, Anti-psychotics, Anti-convulsants, and CNS ...
|
more...
|
$995.00
|

